Laser Focus World is an industry bedrock—first published in 1965 and still going strong. We publish original articles about cutting-edge advances in lasers, optics, photonics, sensors, and quantum technologies, as well as test and measurement, and the shift currently underway to usher in the photonic integrated circuits, optical interconnects, and copackaged electronics and photonics to deliver the speed and efficiency essential for data centers of the future.

Our 80,000 qualified print subscribers—and 130,000 12-month engaged online audience—trust us to dive in and provide original journalism you won’t find elsewhere covering key emerging areas such as laser-driven inertial confinement fusion, lasers in space, integrated photonics, chipscale lasers, LiDAR, metasurfaces, high-energy laser weaponry, photonic crystals, and quantum computing/sensors/communications. We cover the innovations driving these markets.

Laser Focus World is part of Endeavor Business Media, a division of EndeavorB2B.

Laser Focus World Membership

Never miss any articles, videos, podcasts, or webinars by signing up for membership access to Laser Focus World online. You can manage your preferences all in one place—and provide our editorial team with your valued feedback.

Magazine Subscription

Can you subscribe to receive our print issue for free? Yes, you sure can!

Newsletter Subscription

Laser Focus World newsletter subscription is free to qualified professionals:

The Daily Beam

Showcases the newest content from Laser Focus World, including photonics- and optics-based applications, components, research, and trends. (Daily)

Product Watch

The latest in products within the photonics industry. (9x per year)

Bio & Life Sciences Product Watch

The latest in products within the biophotonics industry. (4x per year)

Laser Processing Product Watch

The latest in products within the laser processing industry. (3x per year)

Get Published!

If you’d like to write an article for us, reach out with a short pitch to Sally Cole Johnson: [email protected]. We love to hear from you.

Photonics Hot List

Laser Focus World produces a video newscast that gives a peek into what’s happening in the world of photonics.

Following the Photons: A Photonics Podcast

Following the Photons: A Photonics Podcast dives deep into the fascinating world of photonics. Our weekly episodes feature interviews and discussions with industry and research experts, providing valuable perspectives on the issues, technologies, and trends shaping the photonics community.

Editorial Advisory Board

  • Professor Andrea M. Armani, University of Southern California
  • Ruti Ben-Shlomi, Ph.D., LightSolver
  • James Butler, Ph.D., Hamamatsu
  • Natalie Fardian-Melamed, Ph.D., Columbia University
  • Justin Sigley, Ph.D., AmeriCOM
  • Professor Birgit Stiller, Max Planck Institute for the Science of Light, and Leibniz University of Hannover
  • Professor Stephen Sweeney, University of Glasgow
  • Mohan Wang, Ph.D., University of Oxford
  • Professor Xuchen Wang, Harbin Engineering University
  • Professor Stefan Witte, Delft University of Technology

New Lung Cancer Research Offers Patients Hope

By: NewsUSA

(NewsUSA) - New research in the treatment of small cell lung cancer offers hope to patients.     

Until recently, small cell lung cancer (SCLC) was considered a forgotten cancer, but now there is a new type of chemotherapy treatment and promising research into targeted therapies that may shrink the tumors of a subset of small cell lung cancer patients.     

Small cell lung cancer (SCLC) is currently only treatable by chemotherapy and immunotherapy, and it is difficult to identify, so most patients are already an in advanced stage of cancer when they are diagnosed. SCLC spreads quickly and is resistant to many treatments; it also comes back more aggressively after treatment. However, researchers have identified a subset of SCLC patients who appear to respond to drugs that are already proven cancer fighters; the proteins in the tumors of these patients make them more receptive to targeted therapies, according to the researchers.   

“The next step in the research is enrolling patients in clinical trials, which are safe and the gold standard of care for SCLC patients,” says Dr. Dwight Owen, a medical oncologist at The Ohio State University.     

Dr. Owen recommends that all adults aged 50 years and older with a history of smoking, or who are current smokers, should be screened for lung cancer. However, “anyone with lungs can have lung cancer,” he emphasized.     

Meanwhile, Dr. Owen encourages anyone with a lung cancer diagnosis to ask their doctor about clinical trials, which are often the best resource for the most advanced treatment.     

“Clinical trial research determines if a promising new treatment, drug or device is safe and effective. For many patients, these trials are the best treatment option and provide new treatments that help them live,” he says.     

Many clinical trials are using telemedicine to “take the trial to the patient” to make clinical trials more accessible to more patients.     

“You should always ask questions to make sure you understand what you will need to do to be part of a clinical trial and make sure you are comfortable,” Dr. Owen explains.     

Be sure to ask your medical team about whether clinical trials could be part of your treatment.     

For more information, visit LCFAmerica.org or text L-C-F-A to 41444.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.